{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:21:33Z","timestamp":1790256093419,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.therap.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T20:59:26Z","timestamp":1539377966000},"page":"389-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Identification de cas d\u2019abus\/d\u00e9pendance par le r\u00e9seau fran\u00e7ais d\u2019addictovigilance\u00a0: une \u00e9tude pilote du CEIP-A et du Centre psychoth\u00e9rapique de Nancy"],"prefix":"10.1016","volume":"74","author":[{"given":"Pauline","family":"Barberot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Gibaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia","family":"Benkhedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Dobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Tournebize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2018.10.002_bib0125","series-title":"Addictions","author":"Minist\u00e8re des solidarit\u00e9s et de la sant\u00e9","year":"2018"},{"key":"10.1016\/j.therap.2018.10.002_bib0130","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/papr.12289","article-title":"Are physicians safely prescribing opioids for chronic noncancer pain? A systematic review of current evidence","volume":"16","author":"Tournebize","year":"2016","journal-title":"Pain Pract"},{"key":"10.1016\/j.therap.2018.10.002_bib0135","series-title":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2017"},{"key":"10.1016\/j.therap.2018.10.002_bib0140","series-title":"Association fran\u00e7aise des centres d'addictovigilance, Consult\u00e9 le 4 octobre 2018.\u00c9valuation de la pharmacod\u00e9pendance en France (addictovigilance)","year":"2018"},{"key":"10.1016\/j.therap.2018.10.002_bib0145","series-title":"Article R5132-112","author":"L\u00e9gifrance","year":"2017"},{"key":"10.1016\/j.therap.2018.10.002_bib0150","series-title":"Article R5132-114","author":"L\u00e9gifrance","year":"2017"},{"issue":"4","key":"10.1016\/j.therap.2018.10.002_bib0155","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.therap.2017.01.010","article-title":"Surveillance system on drug abuse: interest of the French national OPPIDUM program of French addictovigilance network","volume":"72","author":"Frauger","year":"2017","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2018.10.002_bib0160","series-title":"Le PMSI, outil de recueil de cas d\u2019abus\u00a0: analyse r\u00e9trospective dans un service des urgences en 2012\u20132013","author":"Diot","year":"2014"},{"key":"10.1016\/j.therap.2018.10.002_bib0165","series-title":"Complications infectieuses li\u00e9es \u00e0 l\u2019injection de substances psychoactives. Comparaison de deux syst\u00e8mes de recueils\u00a0: la notification spontan\u00e9e et le PMSI","author":"Peyriere","year":"2014"},{"issue":"l1","key":"10.1016\/j.therap.2018.10.002_bib0170","first-page":"73","article-title":"Spontaneous addictovigilance notifications (NotS) and hospital medical information system (PMSI) database: two complementary methods of dectection of signals","volume":"26","author":"Berruyer","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.therap.2018.10.002_bib0175","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/pds.3369","article-title":"Identification of abuse and dependence cases through a hospital database","volume":"21","author":"Daveluy","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2018.10.002_bib0180","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2125.2010.03897.x","article-title":"Cannabis-related hospitalizations: unexpected serious events identified through hospital databases","volume":"71","author":"Jouanjus","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.therap.2018.10.002_bib0185","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0013-7006(05)82385-1","article-title":"Pr\u00e9valence et comorbidit\u00e9 des troubles psychiatriques dans la population g\u00e9n\u00e9rale fran\u00e7aise\u00a0: r\u00e9sultats de l\u2019\u00e9tude \u00e9pid\u00e9miologique ESEMeD\/MHEDEA 2000\/(ESEMeD)","volume":"31","author":"Lepine","year":"2005","journal-title":"Encephale"},{"key":"10.1016\/j.therap.2018.10.002_bib0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0013-7006(05)82386-3","article-title":"Usage des psychotropes et troubles psychiatriques en France\u00a0: r\u00e9sultats de l\u2019\u00e9tude \u00e9pid\u00e9miologique ESEMeD\/MHEDEA 2000\/(ESEMeD) en population g\u00e9n\u00e9rale","volume":"31","author":"Gasquet","year":"2005","journal-title":"Encephale"},{"issue":"6","key":"10.1016\/j.therap.2018.10.002_bib0195","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0306-4603(98)00075-6","article-title":"Substance misuse and psychiatric comorbidity\u00a0: an overview of the OPCS national psychiatric morbidity survey","volume":"23","author":"Farrell","year":"1998","journal-title":"Addict Behav"},{"key":"10.1016\/j.therap.2018.10.002_bib0200","series-title":"Classification statistique internationale des maladies et des probl\u00e8mes de sant\u00e9 connexes CIM-10\u00a0FR \u00e0 usage PMSI","author":"Minist\u00e8re des affaires sociales et de la sant\u00e9","year":"2015"},{"key":"10.1016\/j.therap.2018.10.002_bib0205","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.v67n0211","article-title":"Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"67","author":"Conway","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.therap.2018.10.002_bib0210","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1176\/appi.ajp.2017.17020223","article-title":"Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis","volume":"175","author":"Starzer","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.therap.2018.10.002_bib0215","series-title":"CEIP-Addictovigilance PACA-Corse, R\u00e9sultats de l\u2019enqu\u00eate OPPIDUM 2016","year":"2017"},{"key":"10.1016\/j.therap.2018.10.002_bib0220","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.therap.2017.01.010","article-title":"Dispositif pharmaco\u00e9pid\u00e9miologique de surveillance des substances psychoactives\u00a0: int\u00e9r\u00eats du programme national OPPIDUM du R\u00e9seau fran\u00e7ais d\u2019addictovigilance","volume":"72","author":"Frauger","year":"2017","journal-title":"Therapie"},{"issue":"6","key":"10.1016\/j.therap.2018.10.002_bib0225","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/JCP.0000000000000806","article-title":"Prevalence of antipsychotic-treated patients in a cohort of adult addicted patients, J Clin Psychopharmacol","volume":"37","author":"Peyri\u00e8re","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.therap.2018.10.002_bib0230","series-title":"Drogues, chiffres cl\u00e9s","author":"OFDT","year":"2017"},{"key":"10.1016\/j.therap.2018.10.002_bib0235","series-title":"\u00c9tat des lieux de la consommation des benzodiaz\u00e9pines en France","author":"ANSM","year":"2017"},{"key":"10.1016\/j.therap.2018.10.002_bib0120","series-title":"Les troubles bipolaires","author":"Bourgeois","year":"2014"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595718302208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595718302208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:52:41Z","timestamp":1758567161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595718302208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0040595718302208"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2018.10.002","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification de cas d\u2019abus\/d\u00e9pendance par le r\u00e9seau fran\u00e7ais d\u2019addictovigilance\u00a0: une \u00e9tude pilote du CEIP-A et du Centre psychoth\u00e9rapique de Nancy","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}